The SHIELD I trial of D-PLEX 100 – a new formulation of the well-established antibiotic doxycycline – found that giving the drug wasn't able to improve on regular care in preventing infections ...

SHIELD II (Surgical site Hospital acquired Infection prEvention with Local D-PLEX) is a prospective, multinational, randomized, double blind phase 3 trial designed to assess the efficacy and safety of ...